Advertisement
Product › Details
lefamulin (BC-3781)
Next higher product group | antibiotic | |
Status | 2019-08-19 registration start | |
Organisation | Nabriva Therapeutics Forschungs GmbH | |
Today | Nabriva Therapeutics GmbH | |
Group | Nabriva (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for lefamulin (BC-3781)
- [1] F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna....
- [2] Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA....
- [3] Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin....
- [4] Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin....
- [5] Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin....
- [6] Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin....
- [7] Nabriva Therapeutics plc. (11/6/18). "Press Release: Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin....
- [8] Nabriva Therapeutics plc. (8/9/18). "Press Release: Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin....
- [9] Nabriva Therapeutics plc. (7/24/18). "Press Release: Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics". Dublin & King of Prussia, PA....
- [10] Nabriva Therapeutics plc. (5/29/18). "Press Release: Nabriva Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference". Dublin & King of Prussia, PA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top